Research Report on Global and China's Plant-Based Capsule HPMC Market Development Trends and Investment Opportunities (2024-2030)
Release Date:
14 May,2024
Hydroxypropyl methylcellulose (HPMC) is a cellulose derivative that acquires specific physicochemical properties by partially substituting hydroxyl groups on cellulose molecules to form methyl and hydroxypropyl groups.
Hydroxypropyl methylcellulose (HPMC) is a cellulose derivative that acquires specific physicochemical properties by partially substituting hydroxyl groups on cellulose molecules to form methyl and hydroxypropyl groups. HPMC used in plant-based capsules possesses high transparency and suitable mechanical strength, making it a viable alternative to traditional gelatin capsules.
The global market for HPMC in plant-based capsules reached $172 million in sales in 2023 and is projected to reach $308 million by 2030, representing a CAGR of 9.5% (2024-2030). Regionally, the Chinese market has seen rapid growth in recent years, with a market size of [amount missing] million USD in 2023, accounting for approximately [percentage missing]% of the global market. It is projected to reach [amount missing] million USD by 2030, at which point its global share will reach [percentage missing].
In terms of consumption, [region missing] is currently the largest consumer market globally, holding [percentage missing]% market share in 2023, followed by [region missing] and [region missing], holding [percentage missing]% and [percentage missing]% respectively. [Region missing] is expected to experience the fastest growth in the coming years, with a CAGR of approximately [percentage missing]% during 2024-2030.
From a production perspective, North America and Europe are two important production regions, accounting for % and % of the market share respectively in 2023. It is projected that North America and Europe will maintain the fastest growth rate in the coming years, with a projected market share of % by 2030.
In terms of product type, medium viscosity HPMC holds a significant position, with a projected market share of % by 2030. Regarding applications, pharmaceutical capsules accounted for approximately % of the market share in 2023, with a projected CAGR of approximately % over the next few years.
[Note: Content omitted; for full text, please search Zhixin Zhongke Research Network and contact a specialist] One year of free after-sales service; please consult customer service for details and ordering procedures.
From a manufacturer perspective, globally, key manufacturers of HPMC for plant-based capsules include Ashland, Dow, Shin-Etsu, CP Kelco, Luzhou Northern Cellulose, Shandong Heda Group, Shandong Guangda Technology, Ruitai Chemical Group, Huzhou Zhanwang Pharmaceutical, and Shanhe Pharmaceutical Excipients, among others. In 2023, the leading global manufacturers were [Company Name], [Company Name], and [Company Name], holding approximately [Percentage]% market share. The second tier included [Company Name], [Company Name], [Company Name], and [Company Name], collectively holding [Percentage]% market share.
This report studies the global and Chinese markets for HPMC (Heterocyclic Molecule Compound) used in plant-based capsules, including its production capacity, output, sales volume, sales revenue, price, and future trends. It focuses on analyzing the product characteristics, specifications, prices, sales volume, and sales revenue of major manufacturers in the global and Chinese markets, as well as their market share. Historical data covers 2019 to 2023, and forecast data covers 2024 to 2030.
TAG: